The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Prodrugs in medicinal chemistry and enzyme prodrug therapies
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Pharmacokinetics and pharmacodynamics of the new propofol prodrug GPI 15715 in rates
Schywalsky, M., Ihmsen, H., Tzabazis, A., Fechner, J., Burak, E. S., Vornov, J. J., & Schwilden, H. (2005) · European Journal of Anaesthesiology · doi:10.1017/s0265021503000322 · Cited by 41
RetractedAlbumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
Kratz, F. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.010 · Cited by 2,151
Prodrugs: design and clinical applications
Rautio, J., Kumpulainen, H., Heimbach, T., Oliyai, R., Oh, D., Järvinen, T., & Savolainen, J. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2468 · Cited by 1,630
Self-citationHuman UDP-Glucuronosyltransferases: Metabolism, Expression, and Disease
Tukey, R. H., & Strassburg, C. P. (2000) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.581 · Cited by 1,523
Approved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
Discovery of the once-weekly glucagon-like peptide-1 (GLP-1) analogue semaglutide
Lau, J., Bloch, P., Schäffer, L., Pettersson, I., Spetzler, J., Kofoed, J., Madsen, K., Knudsen, L. B., McGuire, J., Steensgaard, D. B., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00726 · Cited by 1,105
Structure-based programming of lymph-node targeting in molecular vaccines
Liu, H., Moynihan, K. D., Zheng, Y., Szeto, G. L., Li, A. V., Huang, B., Van Egeren, D. S., Park, C., & Irvine, D. J. (2014) · Nature · doi:10.1038/nature12978 · Cited by 943
Impact of albumin on drug delivery — New applications on the horizon
Elsadek, B., & Kratz, F. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.09.069 · Cited by 832
Senter, P. D., & Sievers, E. L. (2012) · Nature Biotechnology · doi:10.1038/nbt.2289 · Cited by 763
Walko, C. M., & Lindley, C. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.01.005 · Cited by 659
Prodrug strategies to overcome poor water solubility
Stella, V. J., & Nti-Addae, K. W. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.013 · Cited by 554
Prodrug Strategies in Anticancer Chemotherapy
Kratz, F., Müller, I. A., Ryppa, C., & Warnecke, A. (2008) · ChemMedChem · doi:10.1002/cmdc.200700159 · Cited by 486
The Role of Human Carboxylesterases in Drug Metabolism: Have We Overlooked Their Importance?
Casey Laizure, S., Herring, V., Hu, Z., Witbrodt, K., & Parker, R. B. (2013) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1194 · Cited by 446
Glucose Conjugation for the Specific Targeting and Treatment of Cancer
Calvaresi, E. C., & Hergenrother, P. J. (2013) · Chemical Science · doi:10.1039/c3sc22205e · Cited by 398
Lessons Learned from Marketed and Investigational Prodrugs
Ettmayer, P., Amidon, G. L., Clement, B., & Testa, B. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm0303812 · Cited by 384
Self‐Immolative Spacers: Kinetic Aspects, Structure–Property Relationships, and Applications
Alouane, A., Labruère, R., Le Saux, T., Schmidt, F., & Jullien, L. (2015) · Angewandte Chemie International Edition · doi:10.1002/anie.201500088 · Cited by 379
Beaumont, K., Webster, R., Gardner, I., & Dack, K. (2003) · Current Drug Metabolism · doi:10.2174/1389200033489253 · Cited by 363
A novel connector linkage applicable in prodrug design
Carl, P. L., Chakravarty, P. K., & Katzenellenbogen, J. A. (1981) · Journal of Medicinal Chemistry · doi:10.1021/jm00137a001 · Cited by 351
A clinical update of using albumin as a drug vehicle — A commentary
Kratz, F. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.03.013 · Cited by 334
Fillat, C., Carrio, M., Cascante, A., & Sangro, B. (2003) · Current Gene Therapy · doi:10.2174/1566523033347426 · Cited by 287
Phosphorylation of nucleosides and nucleoside analogs by mammalian nucleoside monophosphate kinases
Van Rompay, A. R., Johansson, M., & Karlsson, A. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(00)00048-6 · Cited by 244
Hostetler, K. Y. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.01.005 · Cited by 244
Perry, C. M., & Faulds, D. (1996) · Drugs · doi:10.2165/00003495-199652050-00009 · Cited by 240
The neonatal Fc receptor, FcRn, as a target for drug delivery and therapy
Sockolosky, J. T., & Szoka, F. C. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.02.005 · Cited by 235
Li, W., Escarpe, P. A., Eisenberg, E. J., Cundy, K. C., Sweet, C., Jakeman, K. J., Merson, J., Lew, W., Williams, M., Zhang, L., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.3.647 · Cited by 223
Rationale for Design of Biologically Reversible Drug Derivatives: Prodrugs
Sinkula, A. A., & Yalkowsky, S. H. (1975) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600640203 · Cited by 223
Mansour, A. M., Drevs, J., Esser, N., Hamada, F. M. A., Badary, O. A., Unger, C., Fichtner, I., & Kratz, F. (2003) · PubMed · Cited by 197
Drucker, D. J., Dritselis, A., & Kirkpatrick, P. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3148 · Cited by 181
Development and Properties of β-Glucuronide Linkers for Monoclonal Antibody−Drug Conjugates
Jeffrey, S. C., Andreyka, J. B., Bernhardt, S. X., Kissler, K. M., Kline, T., Lenox, J. S., Moser, R. F., Nguyen, M. T., Okeley, N. M., Stone, I. J., et al. (2006) · Bioconjugate Chemistry · doi:10.1021/bc0600214 · Cited by 181
Textbook of Drug Design and Discovery
(2016) · CRC Press eBooks · doi:10.1201/9781315371818 · Cited by 175
Birkus, G., Wang, R., Liu, X., Kutty, N., MacArthur, H., Cihlar, T., Gibbs, C., Swaminathan, S., Lee, W., & McDermott, M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00968-06 · Cited by 172
Gene-Directed Enzyme Prodrug Therapy
Zhang, J., Kale, V. M., & Chen, M. (2014) · The AAPS Journal · doi:10.1208/s12248-014-9675-7 · Cited by 163
Self-immolative linkers in polymeric delivery systems
Blencowe, C. A., Russell, A. T., Greco, F., Hayes, W., & Thornthwaite, D. W. (2010) · Polymer Chemistry · doi:10.1039/c0py00324g · Cited by 159
Nitroreductase gene-directed enzyme prodrug therapy: insights and advances toward clinical utility
Williams, E. M., Little, R. F., Mowday, A. M., Rich, M. H., Chan-Hyams, J. V. E., Copp, J. N., Smaill, J. B., Patterson, A. V., & Ackerley, D. F. (2015) · Biochemical Journal · doi:10.1042/bj20150650 · Cited by 157
Staben, L. R., Koenig, S. G., Lehar, S. M., VANDLEN, R. L., Zhang, D., Chuh, J., Yu, S., Ng, C., Guo, J., Liu, Y., et al. (2016) · Nature Chemistry · doi:10.1038/nchem.2635 · Cited by 155
Prodrugs : challenges and rewards
Stella, V. J. (2007) · Cited by 153
Levodopa pharmacokinetics and pharmacodynamics in fluctuating parkinsonian patients
Nutt, J. G., & Woodward, W. R. (1986) · Neurology · doi:10.1212/wnl.36.6.739 · Cited by 149
Trimethyl lock: a trigger for molecular release in chemistry, biology, and pharmacology
Levine, M. N., & Raines, R. T. (2012) · Chemical Science · doi:10.1039/c2sc20536j · Cited by 148
Connors, T. A., & Whisson, M. E. (1966) · Nature · doi:10.1038/210866b0 · Cited by 142
Perez, O. D., Logg, C. R., Hiraoka, K., Diago, O. R., Burnett, R., Inagaki, A., Jolson, D., Amundson, K., Buckley, T., Lohse, D., et al. (2012) · Molecular Therapy · doi:10.1038/mt.2012.83 · Cited by 137
Renoux, B., Raes, F., Legigan, T., Péraudeau, E., Eddhif, B., Poinot, P., Tranoy‐Opalinski, I., Alsarraf, J., Koniev, O., Kolodych, S., et al. (2017) · Chemical Science · doi:10.1039/c7sc00472a · Cited by 137
Wire, M. B., Shelton, M. J., & Studenberg, S. D. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645020-00002 · Cited by 127
β-Glucuronidase-responsive prodrugs for selective cancer chemotherapy: An update
Tranoy‐Opalinski, I., Legigan, T., Barat, R., Clarhaut, J. A., Thomas, M., Renoux, B., & Papot, S. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.12.045 · Cited by 124
Targeting the Delivery of Glycan-Based Paclitaxel Prodrugs to Cancer Cells via Glucose Transporters
Lin, Y.-S., Tungpradit, R., Sinchaikul, S., An, F.-M., Liu, D.-Z., Phutrakul, S., & Chen, S.-T. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8006257 · Cited by 120
Liver-Targeted Drug Delivery Using HepDirect Prodrugs
Erion, M. D., van Poelje, P. D., MacKenna, D. A., Colby, T. J., Montag, A. C., Fujitaki, J. M., Linemeyer, D. L., & Bullough, D. A. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.075903 · Cited by 119
Mauger, A. B., Burke, P. J., Somani, H. H., et al. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00047a002 · Cited by 116
Activation of prodrugs by antibody‐enzyme conjugates: a new approach to cancer therapy
Senter, P. D. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.2.2404820 · Cited by 110
Chapman, T. M., McGavin, J. K., & Noble, S. (2003) · Drugs · doi:10.2165/00003495-200363150-00006 · Cited by 103
Stachulski, A. V., & Meng, X. (2013) · Natural Product Reports · doi:10.1039/c3np70003h · Cited by 98
Furfine, E. S., Baker, C. T., Hale, M. R., Reynolds, D. J., Salisbury, J. A., Searle, A. D., Studenberg, S. D., Todd, D., Tung, R. D., & Spaltenstein, A. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.3.791-798.2004 · Cited by 98
Prodrugs for Targeted Tumor Therapies: Recent Developments in ADEPT, GDEPT and PMT
Tietze, L. F., & Schmuck, K. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798194459 · Cited by 96
Antibody directed enzyme prodrug therapy (ADEPT)
Bagshawe, K. D., Sharma, S. K., Springer, C. J., & Rogers, G. T. (1994) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058725 · Cited by 96
Reductive lactonization of strategically methylated quinone propionic acid esters and amides
Carpino, L. A., Triolo, S. A., & Berglund, R. A. (1989) · The Journal of Organic Chemistry · doi:10.1021/jo00275a012 · Cited by 92
Design of Self-Immolative Linkers for Tumour-Activated Prodrug Therapy
Tranoy‐Opalinski, I., Fernandes, A. E., Thomas, M., GESSON, J. ‐., & Papot, S. (2008) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152008785133065 · Cited by 90
Legigan, T., Clarhaut, J. A., Renoux, B., Tranoy‐Opalinski, I., Monvoisin, A., Berjeaud, J., Guilhot, F., & Papot, S. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300348r · Cited by 88
Self‐Immolative Linkers Literally Bridge Disulfide Chemistry and the Realm of Thiol‐Free Drugs
Frich, C. K., Autzen, A. A. A., & Zelikin, A. N. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500344 · Cited by 87
Self-citationToki, B. E., Cerveny, C. G., Wahl, A. F., & Senter, P. D. (2002) · The Journal of Organic Chemistry · doi:10.1021/jo016187+ · Cited by 86
Mitchell, L., Espinoza, F. L., Mendoza, D., Kato, Y., Inagaki, A., Hiraoka, K., Kasahara, N., Gruber, H. E., Jolly, D. J., & Robbins, J. M. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox037 · Cited by 86
Jourden, J. L. M., Daniel, K. B., & Cohen, S. M. (2011) · Chemical Communications · doi:10.1039/c1cc12526e · Cited by 81
Houba, P. H. J., Boven, E., van der Meulen‐Muileman, I. H., Leenders, R. G. G., Scheeren, J. W., Pinedo, H. M., & Haisma, H. J. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1640 · Cited by 80
A Self-Immolative Spacer That Enables Tunable Controlled Release of Phenols under Neutral Conditions
Schmid, K. M., Jensen, L., & Phillips, S. T. (2012) · The Journal of Organic Chemistry · doi:10.1021/jo300400q · Cited by 80
Warnecke, A., Fichtner, I., Saß, G., & Kratz, F. (2007) · Archiv der Pharmazie · doi:10.1002/ardp.200700025 · Cited by 79
Leu, Y.-L., Roffler, S. R., & Chern, J. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990124q · Cited by 78
Kolakowski, R. V., Haelsig, K. T., Emmerton, K. K., Leiske, C. I., Miyamoto, J. B., Cochran, J. H., Lyon, R. P., Senter, P. D., & Jeffrey, S. C. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201601506 · Cited by 78
Bardsley-Elliot, A., & Noble, S. (1999) · Drugs · doi:10.2165/00003495-199958050-00007 · Cited by 77
Senter, P. D., Pearce, W. E., & Greenfield, R. S. (1990) · The Journal of Organic Chemistry · doi:10.1021/jo00296a082 · Cited by 74
The design and bioactivation of presystemically stable prodrugs
Svensson, L.-Å., & Tunek, A. (1988) · Drug Metabolism Reviews · doi:10.3109/03602538809049622 · Cited by 73
Shi, Y., Zhang, S., & Zhang, X. (2013) · The Analyst · doi:10.1039/c3an36807f · Cited by 69
Synthesis and β-lactamase-mediated activation of a cephalosporin-taxol prodrug
Rodrigues, M. L., Carter, P. M., Wirth, C., Mullins, S., Lee, A. M., & Blackburn, B. K. (1995) · Chemistry & Biology · doi:10.1016/1074-5521(95)90272-4 · Cited by 69
Leu, Y.-L., Chen, C., Wu, Y.-J., & Chern, J. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701151c · Cited by 67
Gluconjugates of 8-hydroxyquinolines as potential anti-cancer prodrugs
Oliveri, V., Giuffrida, M. L., Vecchio, G., Aiello, C., & Viale, M. (2012) · Dalton Transactions · doi:10.1039/c2dt12371a · Cited by 67
The discovery of sofosbuvir: a revolution for therapy of chronic hepatitis C
Gentile, I., Maraolo, A. E., Buonomo, A. R., Zappulo, E., & Borgia, G. (2015) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2015.1094051 · Cited by 67
Design of Selectively Activated Anticancer Prodrugs: Elimination and Cyclization Strategies
Papot, S., Tranoy‐Opalinski, I., Tillequin, F., Florent, J., & GESSON, J. ‐. (2002) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011023354173 · Cited by 66
Secreted human β-glucuronidase: a novel tool for gene-directed enzyme prodrug therapy
Weyel, D., Sedlacek, H.-H., Müller, R., & Brüsselbach, S. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301072 · Cited by 64
McGuigan, C., Hassan-Abdallah, A., Srinivasan, S., Wang, Y., Siddiqui, A. Q., Daluge, S. M., Gudmundsson, K. S., Zhou, H., McLean, E. W., Peckham, J., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060776w · Cited by 61
Reusser, P. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.9.1745 · Cited by 60
Chung, S. W., Choi, J. U., Lee, B. S., Byun, J., Jeon, O., Kim, S. W., Kim, I.-S., Kim, S. Y., & Byun, Y. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.03.043 · Cited by 60
Leenders, R. G. G., Damen, E. W. P., Bijsterveld, E. J. A., Scheeren, H. W., Houba, P. H. J., van der Meulen‐Muileman, I. H., Boven, E., & Haisma, H. J. (1999) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(99)00095-4 · Cited by 57
Zhao, D., Zhang, H., Tao, W., Wei, W., Sun, J., & He, Z. (2017) · Biomaterials Science · doi:10.1039/c6bm00884d · Cited by 55
Tietze, L. F., von Hof, J. M., Müller, M., Krewer, B., & Schuberth, I. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.201002502 · Cited by 54
Liu, D.-Z., Sinchaikul, S., Reddy, P. V. G., Chang, M.-Y., & Chen, S.-T. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.11.008 · Cited by 53
Tietze, L. F., & Krewer, B. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2009.00856.x · Cited by 53
Zhang, Z., Tanabe, K., Hatta, H., & Nishimoto, S. (2005) · Organic & Biomolecular Chemistry · doi:10.1039/b502813b · Cited by 51
Nitroreductase-activated nitric oxide (NO) prodrugs
Sharma, K., Sengupta, K., & Chakrapani, H. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.08.066 · Cited by 51
Hay, M. P., Sykes, B. M., Denny, W. A., & OʼConnor, C. J. (1999) · Journal of the Chemical Society Perkin Transactions 1 · doi:10.1039/a904067f · Cited by 49
Alaoui, A. E., Schmidt, F., Monneret, C., & Florent, J. (2006) · The Journal of Organic Chemistry · doi:10.1021/jo0612675 · Cited by 46
Prodrugs and Targeted Delivery
(2010) · Methods and principles in medicinal chemistry · doi:10.1002/9783527633166 · Cited by 45
Tietze, L. F., Schuster, H., Krewer, B., & Schuberth, I. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8009102 · Cited by 44
Elsadek, B., Graeser, R., Warnecke, A., Unger, C., Saleem, T. H., El-Melegy, N. T., Madkor, H. R., & Kratz, F. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100060m · Cited by 41
Valdez, C. A., Saavedra, J. E., Showalter, B. M., Davies, K. M., Wilde, T. C., Citro, M. L., Barchi, J. J., Deschamps, J. R., Parrish, D. A., El-Gayar, S., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8000482 · Cited by 41
Graeser, R., Chung, D., Esser, N., Moor, S., Schächtele, C., Unger, C., & Kratz, F. (2007) · International Journal of Cancer · doi:10.1002/ijc.23050 · Cited by 41
Ghosh, A. K., Khan, S. R., Marini, F. C., Nelson, J. A., & Farquhar, D. (2000) · Tetrahedron Letters · doi:10.1016/s0040-4039(00)00742-5 · Cited by 39
Chung, D., & Kratz, F. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.07.023 · Cited by 39
Substrate mediated enzyme prodrug therapy
Fejerskov, B., Olesen, M. T. J., & Zelikin, A. N. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.013 · Cited by 39
Self-citationKamal, A., Tekumalla, V., Krishnan, A., Pal‐Bhadra, M., & Bhadra, U. (2008) · ChemMedChem · doi:10.1002/cmdc.200700328 · Cited by 37
Development of Albumin‐binding Doxorubicin Prodrugs that are Cleaved by Prostate‐specific Antigen
Kratz, F., Mansour, A., Soltau, J., Warnecke, A., Fichtner, I., Unger, C., & Drevs, J. (2005) · Archiv der Pharmazie · doi:10.1002/ardp.200500130 · Cited by 37
de Graaf, M., Boven, E., Oosterhoff, D., van der Meulen‐Muileman, I. H., Huls, G. A., Gerritsen, W. R., Haisma, H. J., & Pinedo, H. M. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600143 · Cited by 33
In Vivo Antitumor Activity of Novel Water-Soluble Taxoids
Mikuni, K., Nakanishi, K., Hara, K., Hara, K., Iwatani, W., Amano, T., NAKAMURA, K., Tsuchiya, Y., Okumoto, H., & Mandai, T. (2008) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.31.1155 · Cited by 32
Prijovich, Z. M., Burnouf, P., Chou, H.-C., Huang, P.-T., Chen, K., Cheng, T., Leu, Y.-L., & Roffler, S. R. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00771 · Cited by 32
Substrate Mediated Enzyme Prodrug Therapy
Fejerskov, B., & Zelikin, A. N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049619 · Cited by 28
Self-citationRuiz‐Sanchis, P., Wohl, B. M., Autzen, A. A. A., Zuwała, K., Melchjorsen, J., Tolstrup, M., & Zelikin, A. N. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201400307 · Cited by 26
Self-citationEnzyme Prodrug Therapy Engineered into Biomaterials
Mendes, A. C., & Zelikin, A. N. (2014) · Advanced Functional Materials · doi:10.1002/adfm.201304312 · Cited by 24
Self-citationChen, K., Wu, S.-Y., Leu, Y.-L., Prijovich, Z. M., Chen, B., Wang, H., Cheng, T., & Roffler, S. R. (2011) · Bioconjugate Chemistry · doi:10.1021/bc1005784 · Cited by 24
Saneyoshi, H., Hiyoshi, Y., Iketani, K., Kondo, K., & Ono, A. M. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.10.025 · Cited by 23
The Molecular Design of Prodrugs by Functional Group
Guarino, V. R. (2010) · Methods and principles in medicinal chemistry · doi:10.1002/9783527633166.ch2 · Cited by 3
Cited by
Stimuli-Responsive Therapeutic Metallodrugs
Wang, X., Wang, X., Jin, S., Muhammad, N., & Guo, Z. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00209 · Cited by 649
Disulfide Bond-Driven Oxidation- and Reduction-Responsive Prodrug Nanoassemblies for Cancer Therapy
Sun, B., Luo, C., Yu, H., Zhang, X., Chen, Q., Yang, W., Wang, M., Kan, Q., Zhang, H., Wang, Y., et al. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b00737 · Cited by 426
Selective Targeting of Cancer Cells by Copper Ionophores: An Overview
Oliveri, V. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.841814 · Cited by 367
Probing the impact of sulfur/selenium/carbon linkages on prodrug nanoassemblies for cancer therapy
Sun, B., Luo, C., Zhang, X., Guo, M., Sun, M., Yu, H., Chen, Q., Yang, W., Wang, M., Zuo, S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11193-x · Cited by 319
Progress and Promise of Nitric Oxide‐Releasing Platforms
Yang, T., Zelikin, A. N., & Chandrawati, R. (2018) · Advanced Science · doi:10.1002/advs.201701043 · Cited by 309
Self-citation
Metadata
- Authors
- Walther, R., Rautio, J., & Zelikin, A. N.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2017-09
- Volume
- 118
- Pages
- 65-77
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W2724220888
- Cited by
- 288
- References
- 105
- FWCI
- 6.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.